Cytokinetics, Incorporated
CYTK · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $88.0M | $18.5M | +377% |
| Operating income | −$612M | −$536M | −14.2% |
| Net income | −$785M | −$590M | −33.2% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $47.6M | $1.90M | +2,405% |
| Operating income | −$167M | −$167M | −0.2% |
| Net income | −$190M | −$306M | +37.9% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Cytokinetics's revenue in FY2025?
- $88.0M in FY2025 (Fiscal year ended Dec 31, 2025), +377% vs $18.5M a year earlier, per its 10-K filed Feb 2026.
- Was Cytokinetics profitable in FY2025?
- No: net income was −$785M and operating income −$612M in FY2025.
- What was Cytokinetics's revenue in Q3 2026?
- $47.6M (+2,405% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.